Lou, Z. et al. 2024. Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer. Pakistan Journal of Medical Sciences. 40, 7 (Jun. 2024). DOI:https://doi.org/10.12669/pjms.40.7.9681.